Syncope and Hypoglycemia

Alfonso Lagi

.

DOI: 10.4236/ijcm.2011.22023                

Abstract

Objective: This review focuses on syncope in diabetic patients who suffer from hypoglycemia. Clinically, transient loss of consciousness during hypoglycemia appears similar to vasovagal syncope. Research Design and Methods: Current understanding of this problem is based on physicians’ personal experiences as well as on published case reports. It is difficult to explain a temporary loss of consciousness as a result of hypoglycemia. Demonstration that hypoglycemia can be transient, with the patient suffering from neuroglycopenia without autonomic symptoms due to delayed counterregulation, might be a first step in confirming that a diabetic patient suffered from a transient loss of consciousness with spontaneous recovery. Results: Hypoglycemic syncope is uncommon, affecting 1.9% of diabetic patients using insulin therapy. It is characterized clinically by brief periods of unconsciousness with slow recovery and without loss of postural muscle tone. The difficulty in correlating loss of consciousness to hypoglycemia arises from mismatching symptoms, that is, there may be mental symptoms such as confusion, loss of memory or consciousness, in the absence of autonomic manifestations such as sweating or blurred vision. There are currently no established glucose values that define the level of hypoglycemia that causes loss of consciousness. Conclusion: Hypoglycemic syncope should be suspected in older diabetic patients with preserved postural tone, usually but not always using insulin therapy, who show a slow recovery from transient loss of consciousness with persisting neurological impairment and low blood glucose levels.

Keywords

Syncope, Diabetes, Hypoglycemia, Transient Loss of Consciousness

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	[1] H. Calkins and D. P. Zipes, “Hypotension and Syncope,” In P. Libby, R. O. Bonow and D. L. Mann, Eds., Braun-wald’s Heart Disease, 7th Edition, Elseviers Saunders, Philadelphia, 2005, p. 909-919.
[2]	[2] The Task Force on Syncope, European Society of Cardi-ology, “Guidelines on Management (Diagnosis and Treat- ment) of Syncope-Update 2004,” Europace, Vol. 6, No. 6, 2004, pp. 467-537. doi:10.1016/j.eupc.2004.08.008
[3]	[3] The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). “Guidelines for the Diagnosis and Management of Syn-cope,” European Heart Journal, Vol. 30, No. 21, 2009, pp. 2631-2671.
[4]	[4] The DCCT Research Group, “Adverse Events and Their Association with Treatment Regimens in the Diabetes Control and Complications Trial,” Diabetes Care, Vol. 18, No. 11, 1995, pp. 1415-1427. doi:10.2337/diacare.18.11.1415
[5]	[5] UK Prospective Diabetes Study (UKPDS) Group, “Inten-sive Blood-Glucose Control with Sulphonylureas or Insu-lin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33),” Lancet, Vol. 352, No. 9131, 1998, pp. 837-853. doi:10.1016/S0140-6736(98)07019-6
[6]	[6] American Diabetes Association Workgroup on Hypogly-cemia, “Defining and Reporting Hypoglycaemia in Dia-betes: A Report from the American Diabetes Association Workgroup on Hypoglicemia,” Diabetes Care, Vol. 28, No. 5, 2005, pp. 1245-1249. doi:10.2337/diacare.28.5.1245
[7]	[7] E. M. Bingham, J. T. Dunn, D. Smith, J. Sutcliffe- Goul-den, L. J. Reed, P. K. Marsden and S. A. Amiel, “Differ-ential Changes in Brain Glucose Metabolism During Hy-poglycaemia Accompany Loss of Hypoglycaemia Un-awareness in Men wth Type 1 Diabetes Mellitus: An [11C]-3-O-methyl-D-glucose PET Study,” Diabetologia, Vol. 48, No. 10, 2005, pp. 2080-2089. doi:10.1007/s00125-005-1900-6
[8]	[8] R. J. Wright, B. M. Frier and I. J. Deary, “Effects of Acute Insulin-Induced Hypoglycemia on Spatial Abilities in Adults with Type 1 Diabetes,” Diabetes Care, Vol. 32, No. 8, 2009, pp. 1503-1506. doi:10.2337/dc09-0212
[9]	[9] V. Mc Aulay, I. J. Deary, S. C. Ferguson and B. M. Frier, “Acute Hypoglycemia in Humans Causes Attentional Dysfunction while Nonverbal Intelligence is Preserved,” Diabetes Care, Vol. 24, No. 10, 2001, pp. 1745-1750.
[10]	[10] A. J. Sommerfield, I. J. Deary, V. Mc Aulay and B. M. Frier, “Short-Term, Delayed, and Working Memory are Impaired During Hypoglycemia in Individuals with Type 1 Diabetes,” Diabetes Care, Vol. 26, No. 2, 2003, pp. 390-396. doi:10.2337/diacare.26.2.390